Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$27,000.00

Assessing family doctors' knowledge, attitudes, and practices towards respiratory syncytial virus and pneumococcal vaccination among older adults in Ontario: a mixed-method study

FY 2024-25

Summary
Respiratory syncytial virus (RSV) and Streptococcus pneumoniae (or pneumococcus) are common pathogens that primarily affect the respiratory tract and pose significant health risks, particularly among vulnerable populations such as older adults. Both pathogens often cause asymptomatic infections or mild illness. However, particularly in susceptible groups such as young children and older adults, infection with these pathogens can lead to severe disease, resulting in hospitalizations, long-term complications and even death. Globally, S. pneumoniae and RSV are leading causes of mortality associated with lower respiratory tract infections. In Canada, pneumococcal vaccination has been recommended for older adults since 1989, yet uptake has been slow, with current rates hovering around 50%. Lack of vaccine information and awareness is one of the most cited reasons for low vaccine uptake in this population group.There is limited to no evidence on physician perceptions of pneumococcal and RSV vaccinations of older adults in Canada. Given the recent approval of new pneumococcal and RSV vaccines, it becomes increasingly imperative to understand whether and how family doctors are promoting uptake among high-risk populations. This study will assess family doctors' perspectives concerning RSV and pneumococcal vaccination to understand the current landscape of vaccination practices, identify potential barriers, and explore avenues for improving vaccination rates. This research has the potential to catalyze collaborative efforts, driving improved public health outcomes for Ontario's aging population by identifying effective vaccine strategies and will provide valuable insights for policymakers and other stakeholders to enhance vaccination strategies and educational initiatives.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529726
Name
Wijayakulathilake Yashodya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Assessing family doctors' knowledge, attitudes, and practices towards respiratory syncytial virus and pneumococcal vaccination among older adults in Ontario: a mixed-method study
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Infectious Disease Epidemiology; Older Adults; Ontario Family Doctors; Pneumococcal Disease; Pneumococcal Vaccines; Respiratory Syncytial Virus; Rsv Vaccines; Vaccine Acceptability; Vaccine Epidemiology; Vaccine Uptake
Abstract
Respiratory syncytial virus (RSV) and Streptococcus pneumoniae (or pneumococcus) are common pathogens that primarily affect the respiratory tract and pose significant health risks, particularly among vulnerable populations such as older adults. Both pathogens often cause asymptomatic infections or mild illness. However, particularly in susceptible groups such as young children and older adults, infection with these pathogens can lead to severe disease, resulting in hospitalizations, long-term complications and even death. Globally, S. pneumoniae and RSV are leading causes of mortality associated with lower respiratory tract infections. In Canada, pneumococcal vaccination has been recommended for older adults since 1989, yet uptake has been slow, with current rates hovering around 50%. Lack of vaccine information and awareness is one of the most cited reasons for low vaccine uptake in this population group.There is limited to no evidence on physician perceptions of pneumococcal and RSV vaccinations of older adults in Canada. Given the recent approval of new pneumococcal and RSV vaccines, it becomes increasingly imperative to understand whether and how family doctors are promoting uptake among high-risk populations. This study will assess family doctors' perspectives concerning RSV and pneumococcal vaccination to understand the current landscape of vaccination practices, identify potential barriers, and explore avenues for improving vaccination rates. This research has the potential to catalyze collaborative efforts, driving improved public health outcomes for Ontario's aging population by identifying effective vaccine strategies and will provide valuable insights for policymakers and other stakeholders to enhance vaccination strategies and educational initiatives.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wijayakulathilake, Yashodya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~